Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Accumulated Expenses: 2018-2019

Historic Other Accumulated Expenses for Outlook Therapeutics (OTLK) over the last 2 years, with Sep 2019 value amounting to $1.7 million.

  • Outlook Therapeutics' Other Accumulated Expenses was N/A to $2.6 million in Q2 2020 from the same period last year, while for Jun 2020 it was $2.6 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2019, which is 58.85% up from last year.
  • Latest data reveals that Outlook Therapeutics reported Other Accumulated Expenses of $1.7 million as of FY2019, which was up 58.85% from $1.1 million recorded in FY2018.
  • Outlook Therapeutics' Other Accumulated Expenses' 5-year high stood at $1.7 million during FY2019, with a 5-year trough of $1.1 million in FY2018.
  • Its 2-year average for Other Accumulated Expenses is $1.4 million, with a median of $1.4 million in 2018.
  • Data for Outlook Therapeutics' Other Accumulated Expenses shows a peak YoY spiked of 58.85% (in 2019) over the last 5 years.
  • Yearly analysis of 2 years shows Outlook Therapeutics' Other Accumulated Expenses stood at $1.1 million in 2018, then skyrocketed by 58.85% to $1.7 million in 2019.